Skip to content

To study the effect of Amalaki beej churna in heavy menstrual bleeding

A Randomized open labeled controlled clinical trial to assess an efficacy of Amalaki beej churna with Tandulodaka in the management of Asrugdara with special reference to menorrhagia - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090263
Enrollment
60
Registered
2025-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

Manasi Nitin Sonawane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Selection irrespective of marital status, parity, socioeconomic status. 2. Patients having signs and symptoms of Asrugdara. 3. Excessive bleeding more than 2 consecutive cycles. 4. Excessive bleeding (more than 80ml) or more than 7 days per vagina during mensuration. 5. Hb more than 7 gm percentage

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of Amalaki Beej churna with tandulodaka in Asrugdara W.S.R. to menorrhagiaTimepoint: 1 week,2 week,4 week,3 months

Secondary

MeasureTime frame
To study control on amount and duration of bleeding To study efficacy in reducing associated symptoms To study etiopathology of asrugdara To study disease according to ayurvedic or modern text booksTimepoint: 7th,14th, 28th day for 3 months

Countries

India

Contacts

Public ContactManasi Nitin Sonawane

Matoshree Asarabai Darade Ayurveda Mahavidyalaya Babhulgaon Tal-Yeola Dist-Nashik

sachinmore070979@gmail.com9822874480

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026